Filing Details

Accession Number:
0001213900-23-041331
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-19 08:45:13
Reporting Period:
2023-05-18
Accepted Time:
2023-05-19 08:45:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1690080 180 Life Sciences Corp. ATNF () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1582885 G Pamela Marrone 3000 El Camino Real, Bldg. 4
Suite 200
Palo Alto CA 94306
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-18 7,082 $1.06 12,469 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $1.03 to $1.07, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.